跳转到主要内容
搜索
会议

DIA Japan 2026

Conference: DIA Japan 2026

日期： 2026 年 10 月 18 - 20 日

地点： Tokyo, Japan

Meet Certara at DIA Japan 2026

Certara is pleased to be co-presenting at DIA Japan 2026. Our expert, Mayumi Hasegawa, PhD, joins the “Smart” MIDD in the ICH-M15 Era [S-10 TRACK 7], chaired by Prof. Naoto Uemura, Oita University. ​

​As ICH-M15 advances global harmonization of model-informed drug development, this session explores how regulatory-industry dialogue shapes “MIDD evidence” standards and highlights recent approval successes. Mayumi will present alongside fellow speakers and join a panel discussion.​

Presentation

October 19
11:15-12:45
[S-10 TRACK 7]
"Smart" MIDD in the ICH-M15 Era

Chair: Prof. Naoto Uemura, Oita University​

MIDD Strategies to Overcome Clinical Pharmacology Challenges for Regulatory Approvals

Mayumi Hasegawa, PhD

​

Panel Discussion with All Speakers​

Request a meeting with our experts


Resources in Japanese

精选推荐

Medtech market access: why strategy can’t wait for regulatory approval
Medtech market access: why strategy can’t wait for regulatory approvalBlog

Medtech market access: why strategy can’t wait for regulatory approval

Application of PBPK Modeling Tools in Biopharmaceutics
Application of PBPK Modeling Tools in BiopharmaceuticsWebinar

Application of PBPK Modeling Tools in Biopharmaceutics

Three CDISC standards are converging in 2026. Here’s how to stay ahead of it.
Three CDISC standards are converging in 2026. Here’s how to stay ahead of it.Blog

Three CDISC standards are converging in 2026. Here’s how to stay ahead of it.

事实资料表

From first-in-human trials to global regulatory approvals and post-launch, Certara solutions can help you move your science forward faster, with confidence.

立即下载

沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software